Last Price
0.005
Today's Change
-0.001 (16.66%)
Day's Change
0.005 - 0.006
Trading Volume
91,108,613
Market Cap
26 Million
Shares Outstanding
5 Billion
Avg Volume
12,322,041
Avg Price (50 Days)
0.00
Avg Price (200 Days)
0.01
PE Ratio
-0.50
EPS
-0.01
Earnings Announcement
28-Feb-2024
Previous Close
0.01
Open
0.01
Day's Range
0.005 - 0.006
Year Range
0.003 - 0.0085
Trading Volume
91,108,613
1 Day Change
-16.67%
5 Day Change
-16.67%
1 Month Change
0.00%
3 Month Change
0.00%
6 Month Change
-28.57%
Ytd Change
-28.57%
1 Year Change
-28.57%
3 Year Change
-82.76%
5 Year Change
-88.10%
10 Year Change
-97.22%
Max Change
-99.00%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.